Mayne Pharma soars over 80% on A$604 million Gedeon Richter takeover
Inside FMCG · · AI-summarised by FinFlash
Hungary's Gedeon Richter agreed to buy all of Australia's Mayne Pharma by scheme of arrangement at A$6.40 a share, valuing it at A$604 million. The price is a 99.4% premium to Monday's close and 124% above the 30-day VWAP. Mayne's three largest holders, owning 22.14%, back the deal. Shares jumped more than 80% to A$5.81. Treasurer Jim Chalmers blocked a A$672 million bid from Cosette last year.
So What?
The gap to the offer price reflects regulatory risk given the prior FIRB block; positive read-across for small-cap ASX healthcare M&A.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.